155 related articles for article (PubMed ID: 33364197)
41. Assessment of predictive markers of response to neoadjuvant chemotherapy in breast cancer.
Tewari M; Pradhan S; Singh U; Singh TB; Shukla HS
Asian J Surg; 2010 Oct; 33(4):157-67. PubMed ID: 21377101
[TBL] [Abstract][Full Text] [Related]
42. Basic T1 Perfusion magnetic resonance imaging evaluation of the therapeutic effect of neoadjuvant chemotherapy in locally advanced cervical cancer.
Fu C; Feng X; Bian D; Du W; Wang X; Zhao Y
Int J Gynecol Cancer; 2013 Sep; 23(7):1270-8. PubMed ID: 23970155
[TBL] [Abstract][Full Text] [Related]
43. Expression of vascular endothelial growth factor and proliferation marker MIB1 are influenced by neoadjuvant chemotherapy in locally advanced breast cancer.
Singh M; Capocelli KE; Marks JL; Schleicher RB; Finlayson CA; Seligman PA
Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):147-56. PubMed ID: 15894927
[TBL] [Abstract][Full Text] [Related]
44. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
[TBL] [Abstract][Full Text] [Related]
45. A study on clinico-pathological assessment of response to neoadjuvant chemotherapy in breast carcinoma.
Mohapatra M; Sarma YS
J Cancer Res Ther; 2020; 16(6):1419-1425. PubMed ID: 33342807
[TBL] [Abstract][Full Text] [Related]
46. Predictive value of MGMT, hMLH1, hMSH2 and BRCA1 protein expression for pathological complete response to neoadjuvant chemotherapy in basal-like breast cancer patients.
Nakai K; Mitomi H; Alkam Y; Arakawa A; Yao T; Tokuda E; Saito M; Kasumi F
Cancer Chemother Pharmacol; 2012 Apr; 69(4):923-30. PubMed ID: 22083523
[TBL] [Abstract][Full Text] [Related]
47. Prediction of pathological complete response in breast cancer patients during neoadjuvant chemotherapy: Is shear wave elastography a useful tool in clinical routine?
Maier AM; Heil J; Harcos A; Sinn HP; Rauch G; Uhlmann L; Gomez C; Stieber A; Funk A; Barr RG; Hennigs A; Riedel F; Schäfgen B; Hug S; Marmé F; Sohn C; Golatta M
Eur J Radiol; 2020 Jul; 128():109025. PubMed ID: 32371182
[TBL] [Abstract][Full Text] [Related]
48. Expression of ER, PgR, HER-2, and Ki-67 in core biopsies and in definitive histological specimens in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy.
Rossi L; Verrico M; Tomao S; Ricci F; Fontana A; Spinelli GP; Colonna M; Vici P; Tomao F
Cancer Chemother Pharmacol; 2020 Jan; 85(1):105-111. PubMed ID: 31754747
[TBL] [Abstract][Full Text] [Related]
49. Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer.
McGuire A; Casey MC; Waldron RM; Heneghan H; Kalinina O; Holian E; McDermott A; Lowery AJ; Newell J; Dwyer RM; Miller N; Keane M; Brown JAL; Kerin MJ
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32645898
[TBL] [Abstract][Full Text] [Related]
50. Can quantitative contrast-enhanced ultrasonography predict cervical tumor response to neoadjuvant chemotherapy?
Peng C; Liu LZ; Zheng W; Xie YJ; Xiong YH; Li AH; Pei XQ
Eur J Radiol; 2016 Nov; 85(11):2111-2118. PubMed ID: 27776666
[TBL] [Abstract][Full Text] [Related]
51. The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial.
Dubsky PC; Singer CF; Egle D; Wette V; Petru E; Balic M; Pichler A; Greil R; Petzer AL; Bago-Horvath Z; Fesl C; Meek SM; Kronenwett R; Rudas M; Gnant M; Filipits M;
Eur J Cancer; 2020 Jul; 134():99-106. PubMed ID: 32502940
[TBL] [Abstract][Full Text] [Related]
52. T1 mapping as a surrogate marker of chemotherapy response evaluation in patients with osteosarcoma.
Baidya Kayal E; Sharma N; Sharma R; Bakhshi S; Kandasamy D; Mehndiratta A
Eur J Radiol; 2022 Mar; 148():110170. PubMed ID: 35086004
[TBL] [Abstract][Full Text] [Related]
53. Strain wave elastography in response assessment to neo-adjuvant chemotherapy in patients with locally advanced breast cancer.
Katyan A; Mittal MK; Mani C; Mandal AK
Br J Radiol; 2019 Jul; 92(1099):20180515. PubMed ID: 31045431
[TBL] [Abstract][Full Text] [Related]
54. Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer.
Skarping I; Förnvik D; Zackrisson S; Borgquist S; Rydén L
Breast Cancer Res Treat; 2021 Aug; 189(1):131-144. PubMed ID: 34120224
[TBL] [Abstract][Full Text] [Related]
55. Assessing the Early Response of Advanced Cervical Cancer to Neoadjuvant Chemotherapy Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging: A Pilot Study.
Wang YC; Hu DY; Hu XM; Shen YQ; Meng XY; Tang H; Li Z
Chin Med J (Engl); 2016 Mar; 129(6):665-71. PubMed ID: 26960369
[TBL] [Abstract][Full Text] [Related]
56. The dynamic change of neutrophil to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
Dan J; Tan J; Huang J; Zhang X; Guo Y; Huang Y; Yang J
Breast Cancer; 2020 Sep; 27(5):982-988. PubMed ID: 32306184
[TBL] [Abstract][Full Text] [Related]
57. Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer.
Minarikova L; Bogner W; Pinker K; Valkovič L; Zaric O; Bago-Horvath Z; Bartsch R; Helbich TH; Trattnig S; Gruber S
Eur Radiol; 2017 May; 27(5):1901-1911. PubMed ID: 27651141
[TBL] [Abstract][Full Text] [Related]
58. Radiological and Pathological Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Brief Literature Review.
Parekh T; Dodwell D; Sharma N; Shaaban AM
Pathobiology; 2015 Sep; 82(3-4):124-32. PubMed ID: 26330353
[TBL] [Abstract][Full Text] [Related]
59. Pathological predictive factors for tumor response in locally advanced breast carcinomas treated with anthracyclin-based neoadjuvant chemotherapy.
Patel T; Gupta A; Shah M
J Cancer Res Ther; 2013; 9(2):245-9. PubMed ID: 23771367
[TBL] [Abstract][Full Text] [Related]
60. Accuracy of ultrasound elastography for predicting breast cancer response to neoadjuvant chemotherapy: A systematic review and meta-analysis.
Chen W; Fang LX; Chen HL; Zheng JH
World J Clin Cases; 2022 Apr; 10(11):3436-3448. PubMed ID: 35611212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
